PO.TB08.01 · 肿瘤生物学
Tumor Adhesion
-
7483 · PDF Adhesion plasticity and bidirectional paracrine signaling cooperatively drive glioblastoma invasion Abhinaba Banerjee, Audrey Iwashita, Afsheen Banisadr, Frank Furnari, Adam Engler
-
7484 · PDF Self-made matrix: Tumor-derived Laminin-alpha5 supports pancreatic cancer cell survival and metastatic persistence Annant Bir Kaur, Nivedeta Krishna Kumar, Pratima Raut, Kirtana Arikath, Venkatesh Varadharaj, Zahraa Wajih Alsafwani, Jesse Cox, Poompozhil Mathivanan, Surindar K. Batra, Moorthy P Ponnusamy
-
7485 · PDF RNA modification control of platinum sensitivity via ADAM23-dependent pathway Hao Huang, Ujin Kim, junzui li, Daniela E. Matei
-
7486 · PDF SORL1 promotes mesothelial clearance and migration of ovarian cancer cells through regulating integrin trafficking Jasmine Jathan, Viktoriia Kolesnyk, Samantha Goncalves Novo, Miranda Mansolf, Yang Yang-Hartwich
-
7488 · PDF C-Met and Integrin-alphaV regulated the response of desmoid cells to sorafenib Tianjie Pu, Jia Hu, Vladislav Tsiperson, Lakshana Senthilkumar, Narasimhan P. Agaram, Marco Vincenzo Russo, Ralph Garippa, Samuel Singer, Meera Hameed, Aimee Marie Crago
-
7489 · PDF Unraveling a new ECM stiffening function of the axon guidance molecule Netrin-1 Gaëtan THIVOLLE LIOUX, Laurent Fattet, PATRICK MEHLEN
-
7490 · PDF MYBBP1A is part of a mechanically modulated system that alters breast cancer metastatic potential by regulating focal adhesion Xi Chen, Kent W. Hunter
-
7492 · PDF Preclinical osimertinib-resistant mouse models for advancing third-generation EGFR-TKI drug development Hongyan Sun, Yinuo Wang, Shiying Guo, Yujing Zhang, Huixin Yang, Xiang Gao
-
7493 · PDF Novel preclinical models for evaluating checkpoint inhibitor resistance Hongyan Sun, Yan Wang, Fang Zhu, Yujing Zhang, Huixin Yang, Xiang Gao
-
7494 · PDF Development of enhanced enhertu-resistant HER2-positive breast cancer models for ADC resistance research Hongyan Sun, Yuan Fang, Fang Zhu, Yujing Zhang, Huixin Yang, Xiang Gao
-
7495 · PDF Modeling of de novo and experimentally induced acquired resistance to trastuzumab deruxtecan in HER2-positive patient-derived xenografts Hongyan Sun, Xiaoliu Yang, Shiying Guo, Yujing Zhang, Huixin Yang, Xiang Gao